We serve Chemical Name:1,1,2,2,3,3,3-heptafluoropropyl(trimethyl)silane CAS:3834-42-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1,1,2,2,3,3,3-heptafluoropropyl(trimethyl)silane
CAS.NO:3834-42-2
Synonyms:1-(Trimethylsilyl)heptafluoropropane;Heptafluoropropyl(trimethyl)silane;MFCD00216712;CF3CF2CF2TMS;trimethyl (n-perfluoro propyl) silane
Molecular Formula:C6H9F7Si
Molecular Weight:242.21000
HS Code:2931900090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:88ºC(lit.)
Density:1.195 g/mL at 25ºC(lit.)
Index of Refraction:n20/D 1.324(lit.)
PSA:
Exact Mass:242.03600
LogP:4.11660
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1993 3/PG 2
Packing Group:
Contact us for information like 1-(Trimethylsilyl)heptafluoropropane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,trimethyl (n-perfluoro propyl) silane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,CF3CF2CF2TMS Use and application,Heptafluoropropyl(trimethyl)silane technical grade,usp/ep/jp grade.
Related News: The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease. 1,1,2,2,3,3,3-heptafluoropropyl(trimethyl)silane manufacturer At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances. 1,1,2,2,3,3,3-heptafluoropropyl(trimethyl)silane supplier Retrogenix��s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding. 1,1,2,2,3,3,3-heptafluoropropyl(trimethyl)silane vendor The Philippines reported its first Wuhan coronavirus fatality on Sunday. 1,1,2,2,3,3,3-heptafluoropropyl(trimethyl)silane factory The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease.
